Stay updated on Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Sign up to get notified when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.

Latest updates to the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No other content changes are visible.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure link was removed from the footer. These are maintenance updates and do not affect trial data or functionality.SummaryDifference0.1%

- Check33 days agoChange DetectedAdded Contacts/Locations and Study Status sections on 2025-12-12 and removed the item dated 2025-10-15.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed from the history, reflecting an administrative update to the record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedThe history shows a new revision (v3.3.1) replacing the previous v3.2.0, which appears to be a minor maintenance update that does not alter page content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedDeleted the government funding/operating status notice from the page. The notice previously warned about potential delays in updates due to funding, and its removal does not affect trial information.SummaryDifference0.3%

Stay in the know with updates to Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talazoparib & Enzalutamide in DDR Mutated mCSPC Clinical Trial page.